CSIMarket
 
Edap Tms Sa  (NASDAQ: EDAP)
Other Ticker:  
 
 
Price: $2.5500 $0.11 4.508%
Day's High: $2.57 Week Perf: 10.87 %
Day's Low: $ 2.45 30 Day Perf: 2.41 %
Volume (M): 25 52 Wk High: $ 8.50
Volume (M$): $ 64 52 Wk Avg: $4.53
Open: $2.49 52 Wk Low: $2.00



 Market Capitalization (Millions $) 94
 Shares Outstanding (Millions) 37
 Employees 134
 Revenues (TTM) (Millions $) 68
 Net Income (TTM) (Millions $) -24
 Cash Flow (TTM) (Millions $) -22
 Capital Exp. (TTM) (Millions $) 2

Edap Tms Sa
EDAP TMS SA is a French medical technology company that specializes in the development and commercialization of minimally invasive medical devices for the treatment of urological conditions. The company is primarily known for its expertise in the field of high-intensity focused ultrasound (HIFU) therapy, which uses ultrasound energy to precisely target and destroy cancer cells. EDAP TMS SA's flagship product is the Ablatherm-HIFU, a non-invasive treatment option for localized prostate cancer. The company also offers other innovative products for the diagnosis and treatment of various urological disorders. EDAP TMS SA is committed to improving patients' quality of life through the development of safe, effective, and minimally invasive medical devices.


   Company Address: Parc d?Activites la Poudrette-Lamartine Vaulx-en-Velin 69120
   Company Phone Number: 4 72 15 31 50   Stock Exchange / Ticker: NASDAQ EDAP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARAY        7.33% 
BDX   -8.26%    
BSX        2.58% 
FONR        2.34% 
ISRG        2.91% 
OSUR      0% 
• View Complete Report
   



Edap Tms Sa

Edap Tms Sa Sees Revenue Surge in Fourth Quarter, But Financial Losses Mount

Edap Tms Sa, a leader in the field of Medical Equipment & Supplies, has recently reported its financial results for the October to December 31, 2023 period. Despite a 9.645% increase in revenue to $67.67 million, the company saw a significant widening of its net shortfall per share to $-0.64 from $-0.10 year on year. This marks a substantial increase in the company's financial losses compared to the previous year.
The net shortfall for the period totaled $-23.719 million, a significant increase from $-3.285 million in the same period a year ago. Despite the increase in revenue, the company's losses have grown at a concerning rate, leading to a negative impact on its financial performance.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com